Origin of Water-Stable CsPbX3 Quantum Dots Assisted by Zwitterionic Ligands and Sequential Strategies for Enhanced Luminescence Based on Crystal Evolution

© 2023 Wiley‐VCH GmbH..

Water stability is a crucial issue always addressed for commercial practical application of perovskite quantum dots (QDs). Recent advances in ligand engineering for in situ synthesis of water-stable perovskite QDs have attracted growing interest. However, the exact mechanism remains unclear. Here, the function of 4-bromobutyric acid (BBA) and oleylamine (OLA) is systematically studied in water-stable CsPbX3 (X = Br and I) QDs and confirms that the zwitterionic ligands generated in situ by BBA and OLA are anchored on the QDs surface, thus preventing water from penetrating into the QDs. Cs4PbBr6 intermediate crystal found in the crystal structure evolution process of CsPbX3 QD further reveals a complete crystallization process: PbX2 + CsX + Br- → Cs4PbBr6 crystals + X-→ CsPbX3 QDs + Br-. Furthermore, it is found that the solvent coordination of the precursor solution has a significant effect on the crystallinity of Cs4PbBr6 intermediate crystal, while the Rb+ doping can effectively passivate the surface defects of CsPbX3 QDs, thereby jointly achieving photoluminescence quantum yields (PLQY) of 94.6% for CsPbBr3 QDs (88.2% for CsPbI3 QDs). This work provides new insights and guiding ideas for the green synthesis of high-quality and water-stable perovskite QDs.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:20

Enthalten in:

Small (Weinheim an der Bergstrasse, Germany) - 20(2024), 12 vom: 29. März, Seite e2307042

Sprache:

Englisch

Beteiligte Personen:

Yin, Junyang [VerfasserIn]
Zhang, Jie [VerfasserIn]
Wu, Zhenzi [VerfasserIn]
Wu, Feng [VerfasserIn]
Li, Xiong [VerfasserIn]
Dai, Jiangnan [VerfasserIn]
Chen, Changqing [VerfasserIn]

Links:

Volltext

Themen:

Hydrophobic model
Ion doping
Journal Article
Quantum dots
Solvent coordination
Zwitterionic ligands

Anmerkungen:

Date Revised 23.03.2024

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.1002/smll.202307042

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM36438350X